George I. Getrajdman, MD

About Me

I am a board-certified interventional radiologist with specialized training in image-guided procedures. I have been in practice for almost 30 years and a fellow of the Society of Interventional Radiology for 20 years.

I have served as Director of Interventional Radiology and Co-Director of Memorial Sloan Kettering’s world-renowned Center for Image-Guided Interventions. I am currently a member of the Hepatobiliary, Gynecologic Oncology, and Lymphoma/Leukemia Disease Management Teams. I provide input on minimally invasive and palliative treatments for people with cancer.

When I first joined the Division of Interventional Radiology at MSK in 1993, interventional radiology was still in its early stages. It has been rewarding to be part of a group that has played a major role in defining this field. Now interventional radiology is one of the pillars of cancer care, alongside surgery, oncology, and radiation oncology.

I serve as an investigator on a number of clinical trials. My research focuses on the intravascular treatment of primary liver cancers, such as hepatocellular cancer, and metastatic diseases of the liver. I also devote my time to developing and refining palliative treatments to improve our patients’ quality of life. Biliary interventions, management of fluid collections in the abdomen and chest as well as venous access are particular interests of mine. I hope to continue pursuing this extremely rewarding work and providing the most minimally invasive options for people with cancer.

  • Clinical Expertise: Vascular and Interventional Radiology
  • Languages Spoken: English
  • Education: MD, The Johns Hopkins School of Medicine
  • Residencies: Columbia-Presbyterian Medical Center
  • Fellowships: Columbia-Presbyterian Medical Center
  • Board Certifications: Diagnostic Radiology; CAQ in Interventional Radiology


Visit PubMed for a full listing of George I. Getrajdman’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.